[1]李瑛,胡振斌,张旭,等.中医药治疗肝纤维化研究概况[J].西部中医药,2023,36(07):138-141.[doi:10.12174/j.issn.2096-9600.2023.07.34]
　LI Ying,HU Zhenbin,ZHANG Xu,et al.Research Overview of TCM Treatment of Liver Fibrosis[J].Western Journal of Traditional Chinese Medicine,2023,36(07):138-141.[doi:10.12174/j.issn.2096-9600.2023.07.34]
点击复制

中医药治疗肝纤维化研究概况
分享到：

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
36
期数:
2023年07期
页码:
138-141
栏目:
出版日期:
2023-07-15

文章信息/Info

Title:
Research Overview of TCM Treatment of Liver Fibrosis
作者:
李瑛1, 胡振斌2, 张旭1, 徐昆1, 陈彩凤1
1.广西中医药大学，广西 南宁 530000
2.广西中医药大学第一附属医院，广西 南宁 530000
Author(s):
LI Ying1, HU Zhenbin2, ZHANG Xu1, XU Kun1, CHEN Caifeng1
1.Guangxi University of Chinese Medicine, Nanning 530000, China
2.The First Affiliated Hospital of Guangxi University of Chinese Medicine, Nanning 530000, China
关键词:
肝纤维化; 中医药; 综述
Keywords:
liver fibrosis; TCM; review
分类号:
R242
DOI:
10.12174/j.issn.2096-9600.2023.07.34
文献标志码:
A
摘要:
对近五年中医药治疗肝纤维化（liver fibrosis，HF）的疗效及动物实验研究进行综述，指出HF是一种受多种因素影响的肝损伤愈合反应，是各种慢性肝病的共同病理基础，目前现代医药尚无特效方法与药物，仍需寻找更为有效的终止HF进展甚或逆转至正常、减轻患者痛苦和提高患者生活质量的治疗方法；近年来大量临床数据证实扶正化瘀片、安络化纤丸、鳖甲煎丸、复方鳖甲软肝片等抗HF疗效显著。
Abstract:
By conducting an overviewing of clinical effects of TCM therapy of hepatic fibrosis (HF) and animal experimental research, HF is a kind of liver injury healing response influenced by many factors, as a common pathological basis of all kinds of chronic liver diseases, there was no specific method and drugs in modern medicine, we still need to find more effective therapies in order to stop the progression of HF or even reverse to normal, reduce the patients' pain and improve the patients' quality of life; in the recent years, large amounts of clinical data has proved that Fuzheng Huayu tablets, Anluo Huaqian pills, Biejiajian pills and compound Biejia Ruangan tables present noticeable clinical effects in the treatment of HF.

相似文献/References:

[1]蔺彩娟,甘欣锦△.自拟三子补血汤 治疗化疗后骨髓抑制的经验[J].西部中医药,2012,25(10):47.
　LIN Cai-juan,GAN Xin-jin.Experience on Treating Arrest of Bone Marrow after Chemotherapy with Self-made SanZi BuXueTang[J].Western Journal of Traditional Chinese Medicine,2012,25(07):47.
[2]聂静怡,应森林.周边国家和地区中医药国际教育需求分析[J].西部中医药,2013,26(01):48.
　NIE Jingyi,YING Senlin.Analysis on the Demand of TCM International Education in the Districts and Its Neighboring Countries[J].Western Journal of Traditional Chinese Medicine,2013,26(07):48.
[3]舒劲,杨宏武.中医药在突发公共卫生事件中的应用与探讨[J].西部中医药,2013,26(01):59.
　SHU Jin,YANG Hongwu.Exploration and Application of TCM in the Public Health Emergencies[J].Western Journal of Traditional Chinese Medicine,2013,26(07):59.
[4]鲁培俊,文建强,王冠华,等.兰州市社区卫生服务机构中医药健康教育资源现状调查分析[J].西部中医药,2013,26(01):72.
　LU Peijun,WEN Jianqiang,WANG Guanhua,et al.Investigation on Current State of TCM Health Education Resources in Lanzhou Community Health Service Institutes[J].Western Journal of Traditional Chinese Medicine,2013,26(07):72.
[5]张海清,赵继荣△,陈文.腰椎间盘突出症的中医药治疗概述[J].西部中医药,2012,25(12):124.
　ZHANG Hai-qing,ZHAO Ji-rong,CHEN Wen.On TCM Therapy for Lumbar Intervertebral Disc Protrusion[J].Western Journal of Traditional Chinese Medicine,2012,25(07):124.
[6]李步满,卢世秀.中医药治疗更年期综合征的思路与方法[J].西部中医药,2013,26(11):44.
　LI Buman,LU Shixiu.Thinking and Method of TCM Therapy for Climacteric Syndrome[J].Western Journal of Traditional Chinese Medicine,2013,26(07):44.
[7]郑辉,邓灵芝,张侬△,等.敦煌《灸经图》之“手小指头” “足小指头” “手十指头”穴[J].西部中医药,2012,25(08):51.
　ZHENG Hui,DENG Ling-zhi,ZHANG Nong,et al.Shou XiaoZhiTou, Zu XiaoZhiTou and ShouShiZhiTou Acupoints in JiuJingTu of Dunhuang[J].Western Journal of Traditional Chinese Medicine,2012,25(07):51.
[8]于立友,汪龙德△,张晶,等.化纤保肝方治疗气滞血瘀型肝纤维化的临床研究*[J].西部中医药,2013,26(10):84.
　YU Liyou,WANG Longde,ZHANG Jing,et al.Clinical Study on HuaQian BaoGan Prescription in the Treatment for Hepatic Fibrosis of Qi Staganation and Blood Stasis Pattern[J].Western Journal of Traditional Chinese Medicine,2013,26(07):84.
[9]李双霞,张凤琴,李 娜.中医药在腹部术后胃肠功能恢复中的应用[J].西部中医药,2013,26(08):127.
　LI Shuangxia,ZHANG Fengqin,LI Na.Application of TCM to the Recovery of Gastrointestinal Function of the Patients Undergoing Abdominal Surgery[J].Western Journal of Traditional Chinese Medicine,2013,26(07):127.
[10]孙大伟,王凡,许国,等.体质干预治疗2型糖尿病前期患者33例[J].西部中医药,2014,27(01):104.
　SUN Dawei,WANG Fan,XU Guo,et al.Clinical Observation on Constitution Intervention in the Treatment for 33 Patients with Prediabetes of Type 2[J].Western Journal of Traditional Chinese Medicine,2014,27(07):104.
[11]张玉玲,闫雪华△,谢青.中药联合抗病毒药物治疗HBV所致肝纤维化的研究进展[J].西部中医药,2019,32(06):149.
　ZHANG Yuling,YAN Xuehua,XIE Qing.The Progress of Herbs Joined with Antiviral Drugs in the Treatment for HBV - induced Hepatic Fibrosis[J].Western Journal of Traditional Chinese Medicine,2019,32(07):149.
[12]陈彩凤,胡振斌,黄家程,等.活血化瘀法治疗肝纤维化的研究进展[J].西部中医药,2022,35(12):166.[doi:10.12174/j.issn.2096-9600.2022.12.39]
　CHEN Caifeng,HU Zhenbin,HUANG Jiacheng,et al.Advances in Blood-activating Stasis-resolving Method in the Treatment of Hepatic Fibrosis[J].Western Journal of Traditional Chinese Medicine,2022,35(07):166.[doi:10.12174/j.issn.2096-9600.2022.12.39]
[13]赵迪,徐佳.中医药抗肝纤维化疗效评价的探索[J].西部中医药,2023,36(04):150.[doi:10.12174/j.issn.2096-9600.2023.04.35]
　ZHAO Di,Xu jia.Exploration on the Evaluation of Therapeutic Effects of TCM on Liver Fibrosis[J].Western Journal of Traditional Chinese Medicine,2023,36(07):150.[doi:10.12174/j.issn.2096-9600.2023.04.35]

备注/Memo

备注/Memo:
李瑛（1994—），女，硕士学位。研究方向：肝病的中医药防治。国家科技重大专项课题子课题（2018ZX107255050002）。
更新日期/Last Update: 2023-07-15